{"product_id":"global-stem-cell-therapy-market-growth-status-and-outlook-2023-2029","title":"Global Stem Cell Therapy Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Stem Cell Therapy Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eStem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Stem Cell Therapy Industry Forecast” looks at past sales and reviews total world Stem Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Stem Cell Therapy sales for 2023 through 2029. With Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stem Cell Therapy industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Stem Cell Therapy market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stem Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stem Cell Therapy.\u003c\/p\u003e\n\n\u003cp\u003eThe global Stem Cell Therapy market size is projected to grow from US$ 469.1 million in 2022 to US$ 1724 million in 2029; it is expected to grow at a CAGR of 20.4% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eNorth America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.\u003c\/p\u003e\n\n\u003cp\u003eThe key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Therapy market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003c\/p\u003e\n\n \u003cp\u003eAutologous\u003c\/p\u003e\n\n \u003cp\u003eAllogeneic\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003c\/p\u003e\n\n \u003cp\u003eMusculoskeletal Disorder\u003c\/p\u003e\n\n \u003cp\u003eWounds \u0026amp; Injuries\u003c\/p\u003e\n\n \u003cp\u003eCornea\u003c\/p\u003e\n\n \u003cp\u003eCardiovascular Diseases\u003c\/p\u003e\n\n \u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003c\/p\u003e\n\n \u003cp\u003eAmericas\u003c\/p\u003e\n\n \u003cp\u003eUnited States\u003c\/p\u003e\n\n \u003cp\u003eCanada\u003c\/p\u003e\n\n \u003cp\u003eMexico\u003c\/p\u003e\n\n \u003cp\u003eBrazil\u003c\/p\u003e\n\n \u003cp\u003eAPAC\u003c\/p\u003e\n\n \u003cp\u003eChina\u003c\/p\u003e\n\n \u003cp\u003eJapan\u003c\/p\u003e\n\n \u003cp\u003eKorea\u003c\/p\u003e\n\n \u003cp\u003eSoutheast Asia\u003c\/p\u003e\n\n \u003cp\u003eIndia\u003c\/p\u003e\n\n \u003cp\u003eAustralia\u003c\/p\u003e\n\n \u003cp\u003eEurope\u003c\/p\u003e\n\n \u003cp\u003eGermany\u003c\/p\u003e\n\n \u003cp\u003eFrance\u003c\/p\u003e\n\n \u003cp\u003eUK\u003c\/p\u003e\n\n \u003cp\u003eItaly\u003c\/p\u003e\n\n \u003cp\u003eRussia\u003c\/p\u003e\n\n \u003cp\u003eMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n \u003cp\u003eEgypt\u003c\/p\u003e\n\n \u003cp\u003eSouth Africa\u003c\/p\u003e\n\n \u003cp\u003eIsrael\u003c\/p\u003e\n\n \u003cp\u003eTurkey\u003c\/p\u003e\n\n \u003cp\u003eGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003c\/p\u003e\n\n \u003cp\u003eOsiris Therapeutics\u003c\/p\u003e\n\n \u003cp\u003eNuVasive\u003c\/p\u003e\n\n \u003cp\u003eChiesi Pharmaceuticals\u003c\/p\u003e\n\n \u003cp\u003eJCR Pharmaceutical\u003c\/p\u003e\n\n \u003cp\u003ePharmicell\u003c\/p\u003e\n\n \u003cp\u003eMedi-post\u003c\/p\u003e\n\n \u003cp\u003eAnterogen\u003c\/p\u003e\n\n \u003cp\u003eMolmed\u003c\/p\u003e\n\n \u003cp\u003eTakeda (TiGenix)\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 88 Pages \/ MCW16225943","offer_id":47640100077874,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-stem-cell-therapy-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}